Navigation Links
Oral Contraceptive Pills Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023
Date:2/1/2016

LONDON, Feb.1, 2016 /PRNewswire/ -- Oral contraceptive pills are birth control pills including progestin and estrogen hormones. These hormones induce contraception/birth control by preventing ovulation. These pills are also known as combined pills or combined oral contraceptive pills (COCP). Combined oral contraceptive pills are available in five different packs: the 21-day pack, the 24-day pack, the 28-day pack, the 91-day pack and the four-phase regimen. Bayer's Yaz and Loestrin are the most widely preferred brands of the 24-day pack. Barr Laboratories' Seasonale and Teva Pharmaceutical Industries' Seasonique are preferred in the 91-day pack sub-segment. In the four-phase regimen, Bayer's Natazia dominates the market.

Oral contraceptive pills are the most common form of reversible contraception in the developed economies of the world such as the U.S., Canada, the Western Europe and Australia. Their high effectiveness (99.9% when accurately used and 92% when typically used) and convenience in use (in comparison to contraceptive devices, especially implants), drive the oral contraceptive pills segment.

This report provides in-depth analysis of the global oral contraceptives pills market. The stakeholders for this report include companies involved in the research and development, manufacturing and commercialization of oral contraceptive pills, suppliers and new entrants planning to invest in this market. For providing a snapshot of this market to the stakeholders, executive summary section is included in this report, which summarizes the market size, trends and competition for different oral contraceptive pills in the five major regions.

The market overview section of this report analyzes market dynamics such as drivers, restraints and opportunities that influence the oral contraceptive pills market in the current and future scenario. Further, Porter's five forces analysis and market attractiveness analysis have been included in market overview section in order to explain the intensity of competition in the market. Porter's five forces analysis is also elucidated in the section to understand the attractiveness of the oral contraceptive pills market in terms of the five different attributes that have an effect on the sustenance of the players in the oral contraceptive pills market.

Competitive scenario among the market players is analyzed through a heat map of major market players in the competitive landscape section of the report. All these factors will help the market players to decide about the business strategies and plans to be incurred in future for strengthening their position in the global market.

Based on the product types, the global oral contraceptives market is segmented into combination pills, progestin only pills and others. Combination pills are further categorized into three segments including monophasic pills, triphasic pills and others. Market revenue in terms of US$ Mn for the period 2013 to 2023 along with the compound annual growth rate (CAGR %) from 2015 to 2023 is analyzed for the various types of oral contraceptive pills.

Geographically, the oral contraceptive pills market has been differentiated into five major regions: North America, Europe, Asia Pacific, Latin America and Rest of the World (RoW). This section of the report provides with the market estimation in terms of revenue (US$ Mn) of contraceptive pills market in these five regions from 2013 to 2023. Market revenue for oral contraceptive pills is also provided for geographies along with CAGR % for period 2015 to 2023, considering 2014 as the base year.

This report also includes recommendations section that will assist new companies in establishing their presence and market players in expanding their market share in the oral contraceptive pills market. The report concludes with the company profile section which includes company overview, financial overview, product portfolio, business strategies and recent developments for market players. The major players that are profiled in the report include Actavis, Inc., Bayers AG, Merck & Co., Inc., and Teva Pharmaceutical Industries Ltd.

The global oral contraceptive pills market is segmented into the following categories:
Global Oral Contraceptive Pills Market, by Types
Combination
Monophasic
Triphasic
Others
Progestin Only
Others

Global Oral Contraceptive Pills Market, by Category
Generic
Branded

Global Oral Contraceptive Pills Market, by Geography
North America
U.S.
Canada
Europe
Germany
U.K.
Rest of Europe
Asia Pacific
China
Japan
Rest pf APAC
Latin America
Brazil
Rest of LATAM
Middle East & Africa
Saudi Arabia
Rest of MEA
Download the full report: https://www.reportbuyer.com/product/3588410/

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: www.reportbuyer.com


'/>"/>
SOURCE ReportBuyer
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Medicines360 and Camargo Pharmaceutical Gain FDA Approval for Intrauterine Contraceptive Device
2. Oral Contraceptive Pills Market to Reach US$22.9 bn by 2023, Strong Demand Projected for Combination Contraceptive Pills: Transparency Market Research
3. Need to Prevent Sexually Transmitted Diseases (STIs) for Public Health Drives Global Contraceptives Market: Transparency Market Research
4. Global Female Contraceptives Market 2015-2019 with Allergan, Merck, Pfizer & Teva Pharmaceutical Dominating
5. Global Intrauterine Contraceptive Devices market to be Worth $3,655.5 Million by 2019, at a Developing CAGR of 3.3% from 2014 to 2019
6. Global Contraceptive Devices Market 2015-2019 with Ansell, Actavis, Bayer, Church & Dwight & Merck & Co Dominating
7. Aquila Solutions, LLC Partners with Evofem, Inc. to Submit New Drug Application to U.S. FDA for Amphora as a Contraceptive
8. North American Intrauterine Contraceptive Devices Market is Expected to Reach $789.8 Million by 2019, at a CAGR of 0.3% From 2014 to 2019
9. Micro Market Monitor: Global Intrauterine Contraceptive Devices Market Research Report
10. Global Contraceptives Market 2014-2018: Key Vendors are Actavis, Bayer, Johnson & Johnsons, Janssen, Merck & Co, Pfizer and Teva
11. Global Contraceptives Market Report 2013: Forecasts to 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2019)... , ... September 17, 2019 , ... Drs. Nickelice Brand ... implant placement and restorations in one office. Dental implants are a nearly permanent, ... loss. , Dental implants have a high success rate when placed by highly trained ...
(Date:9/17/2019)... ... September 17, 2019 , ... Summer is a time for barbecues, parties and picnics ... our teeth and gums. Dr. Douglas Ng, family dentist in San Luis Obispo ... time for ice cream, and popsicles and ice-filled cold drinks to go along with the ...
(Date:9/14/2019)... CULVER CITY, Calif. (PRWEB) , ... ... ... recent World Molecular Imaging Society (WMIS) annual congress in Montreal provided a ... the studies highlighted presentations on Artificial Intelligence (AI) to detect breast cancer, ...
Breaking Medicine Technology:
(Date:9/17/2019)... ... September 17, 2019 , ... Six Consulting Inc. (SIX) ... of canines – specifically golden retrievers - through innovative cancer prevention medicine. A ... – one out of five retrievers in the United States will die from ...
(Date:9/17/2019)... ... September 17, 2019 , ... Caravan Health is ... in the country, the company announced today. High-performing community health systems and providers ... increase cost efficiency. This opportunity is open to those new to value-based Medicare ...
(Date:9/17/2019)... Calif. (PRWEB) , ... September 17, 2019 , ... ... , CA, recently announced that he has been certified by the American Academy ... dentistry is used to correct a wide range of orofacial conditions such as ...
(Date:9/17/2019)... ... September 17, 2019 , ... The Center for Information ... of the third edition of The Gift of Participation. Written by CISCRP Founder, ... families to navigate the clinical research process. The new edition offers a fresh ...
(Date:9/14/2019)... ... September 13, 2019 , ... ... showcased several first-in-human studies on the detection and treatment of infectious diseases ... of these ground-breaking studies were noninvasive detection of residual HIV infected cell ...
Breaking Medicine News(10 mins):